Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Lymphocytic, Chronic. B-Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00535873
What this trial is testing

Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older

Who this might be right for
LeukemiaCLLChronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 61
Early research (Phase 1)Active Not RecruitingNCT02787369
What this trial is testing

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

Who this might be right for
Recurrent Chronic Lymphoid Leukemia
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT00006225
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+2 more
Northwestern University
Early research (Phase 1)Study completedNCT04018248
What this trial is testing

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

Who this might be right for
Diffuse Large B Cell LymphomaFollicular LymphomaChronic Lymphocytic Leukemia+5 more
Boryung Pharmaceutical Co., Ltd 26
Testing effectiveness (Phase 2)Study completedNCT00104858
What this trial is testing

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more
Fred Hutchinson Cancer Center 66
Large-scale testing (Phase 3)Study completedNCT03480360
What this trial is testing

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Dartmouth-Hitchcock Medical Center 21
Early research (Phase 1)Study completedNCT01955668
What this trial is testing

AZD6738 First Time in Patient Multiple Ascending Dose Study

Who this might be right for
11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),Prolymphocytic Leukaemia (PLL)B Cell Lymphomas
AstraZeneca 2
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Not applicableStudy completedNCT04290923
What this trial is testing

Determination of Blood Tumor Cells

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellAbnormalities Cell Epithelial
University of Zurich 71
Testing effectiveness (Phase 2)Ended earlyNCT00265915
What this trial is testing

Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Active Not RecruitingNCT04072458
What this trial is testing

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

Who this might be right for
Mantle Cell LymphomaPeripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL)+7 more
Bio-Path Holdings, Inc. 30
Early research (Phase 1)Study completedNCT02280525
What this trial is testing

Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00052520
What this trial is testing

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+20 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Testing effectiveness (Phase 2)Study completedNCT01392079
What this trial is testing

Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine

Who this might be right for
Chronic Lymphocytic Leukemia
University of Ulm 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06367374
What this trial is testing

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 66
Testing effectiveness (Phase 2)Study completedNCT03204188
What this trial is testing

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
B-Cell Chronic Lymphocytic LeukemiaB-Lymphocytic Leukemia, ChronicChronic Lymphocytic Leukemia+6 more
National Heart, Lung, and Blood Institute (NHLBI) 15
Testing effectiveness (Phase 2)Ended earlyNCT01013961
What this trial is testing

Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
ECOG-ACRIN Cancer Research Group 31
Testing effectiveness (Phase 2)Study completedNCT00980395
What this trial is testing

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma

Who this might be right for
LymphomaMantle Cell LymphomaIndolent Lymphoma+1 more
University of Arizona 24
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872
What this trial is testing

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 547
Next Page